Search by Drug Name or NDC
NDC 00049-3190-28 VFEND 10 mg/mL Details
VFEND 10 mg/mL
VFEND is a INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Roerig. The primary component is VORICONAZOLE.
Product Information
| NDC | 00049-3190 |
|---|---|
| Product ID | 0049-3190_f098cc33-f6ee-4a49-9329-cbc1d1c31bd2 |
| Associated GPIs | 11407080002120 |
| GCN Sequence Number | 050444 |
| GCN Sequence Number Description | voriconazole VIAL 200 MG INTRAVEN |
| HIC3 | W3B |
| HIC3 Description | ANTIFUNGAL AGENTS |
| GCN | 17499 |
| HICL Sequence Number | 023720 |
| HICL Sequence Number Description | VORICONAZOLE |
| Brand/Generic | Brand |
| Proprietary Name | VFEND |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Voriconazole |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Route | INTRAVENOUS |
| Active Ingredient Strength | 10 |
| Active Ingredient Units | mg/mL |
| Substance Name | VORICONAZOLE |
| Labeler Name | Roerig |
| Pharmaceutical Class | Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA] |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA021267 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00049-3190-28 (00049319028)
| NDC Package Code | 0049-3190-28 |
|---|---|
| Billing NDC | 00049319028 |
| Package | 1 VIAL, SINGLE-DOSE in 1 CARTON (0049-3190-28) / 20 mL in 1 VIAL, SINGLE-DOSE |
| Marketing Start Date | 2003-03-28 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |